Declining drinking among adolescents: Are we seeing a denormalisation of drinking and a normalisation of non-drinking?


Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
05 2022
Historique:
received: 03 02 2021
accepted: 08 06 2021
pubmed: 24 6 2021
medline: 6 4 2022
entrez: 23 6 2021
Statut: ppublish

Résumé

In the early 2000s, alcohol use among young people began to decline in many western countries, especially among adolescents (ages between 12-17 years old). These declines have continued steadily over the past two decades, against the backdrop of much smaller declines among the general population. Hypotheses examining individual factors fail adequately to provide the necessary 'big picture' thinking needed to understand declines in adolescent drinking. We use the normalisation thesis to argue that there is strong international evidence for both processes of denormalisation of drinking and normalisation of non-drinking occurring for adolescents in many western countries. Research on declining adolescent drinking provides evidence of both denormalisation of alcohol consumption and normalisation of non-drinking. This has implications for enabling policy environments more amenable to regulation and increasing the acceptability of non-drinking in social contexts. Normalisation theory (and its various interpretations) provides a useful multi-dimensional tool for understanding declines in adolescent drinking.

Sections du résumé

BACKGROUND
In the early 2000s, alcohol use among young people began to decline in many western countries, especially among adolescents (ages between 12-17 years old). These declines have continued steadily over the past two decades, against the backdrop of much smaller declines among the general population.
ARGUMENT
Hypotheses examining individual factors fail adequately to provide the necessary 'big picture' thinking needed to understand declines in adolescent drinking. We use the normalisation thesis to argue that there is strong international evidence for both processes of denormalisation of drinking and normalisation of non-drinking occurring for adolescents in many western countries.
CONCLUSIONS
Research on declining adolescent drinking provides evidence of both denormalisation of alcohol consumption and normalisation of non-drinking. This has implications for enabling policy environments more amenable to regulation and increasing the acceptability of non-drinking in social contexts. Normalisation theory (and its various interpretations) provides a useful multi-dimensional tool for understanding declines in adolescent drinking.

Identifiants

pubmed: 34159676
doi: 10.1111/add.15611
pmc: PMC7614939
mid: EMS184778
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1204-1212

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 208090/Z/17/Z
Pays : United Kingdom

Informations de copyright

© 2021 Society for the Study of Addiction.

Références

Addiction. 2021 Jan;116(1):62-71
pubmed: 32285975
Alcohol Alcohol. 2012 Jul-Aug;47(4):479-85
pubmed: 22459020
Int J Drug Policy. 2021 May;91:102825
pubmed: 32593513
Drug Alcohol Rev. 2020 Mar;39(3):246-254
pubmed: 31970851
Subst Use Misuse. 2011;46(10):1244-55
pubmed: 21619443
Int J Drug Policy. 2019 Feb;64:13-20
pubmed: 30544091
Subst Use Misuse. 2003 Dec;38(14):1983-2016
pubmed: 14677779
Int J Drug Policy. 2018 Mar;53:106-112
pubmed: 29331756
Eur J Public Health. 2019 Feb 1;29(1):27-32
pubmed: 30169631
Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S42-S48
pubmed: 29405460
Int J Drug Policy. 2017 Nov;49:8-14
pubmed: 28822894
Int J Drug Policy. 2015 Apr;26(4):371-9
pubmed: 25217801
Alcohol Alcohol. 2016 Jul;51(4):383-7
pubmed: 26755639
Drug Alcohol Rev. 2014 May;33(3):227-34
pubmed: 24372933
BMC Public Health. 2018 Oct 10;18(1):1090
pubmed: 30301472
Drug Alcohol Rev. 2015 Mar;34(2):115-8
pubmed: 25756218
Subst Use Misuse. 2019;54(5):831-840
pubmed: 30618328
BMC Public Health. 2017 Jun 9;17(1):560
pubmed: 28599649
Drug Alcohol Rev. 2010 Sep;29(5):525-30
pubmed: 20887576
Int J Environ Res Public Health. 2017 Jun 16;14(6):
pubmed: 28621753
Alcohol Alcohol. 2014 May-Jun;49(3):336-42
pubmed: 24005573
J Stud Alcohol Drugs. 2016 Sep;77(5):700-9
pubmed: 27588528
Nordisk Alkohol Nark. 2019 Aug;36(4):344-356
pubmed: 32934572
Drug Alcohol Rev. 2016 Jul;35(4):424-32
pubmed: 26494533
Am J Public Health. 2013 Jun;103(6):1090-5
pubmed: 23597385
Int J Drug Policy. 2020 Jul;81:102780
pubmed: 32423660
Addiction. 2010 Jul;105(7):1205-13
pubmed: 20491726
Alcohol Alcohol. 2017 Jul 01;52(4):487-495
pubmed: 28379324
BMC Public Health. 2016 Apr 14;16:325
pubmed: 27074975
Addiction. 2016 Sep;111(9):1590-8
pubmed: 27351584
J Stud Alcohol Drugs. 2021 Jan;82(1):76-83
pubmed: 33573725
Int J Drug Policy. 2020 Jul;81:102655
pubmed: 32033857
Am J Prev Med. 2006 Sep;31(3):225-32
pubmed: 16905033
Addiction. 2020 Feb;115(2):230-238
pubmed: 31560404
BMC Public Health. 2012 Jun 29;12:491
pubmed: 22747699
Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S98-S114
pubmed: 29573020
Alcohol Clin Exp Res. 2008 Dec;32(12):2149-60
pubmed: 18828796
Med J Aust. 2011 Dec 19;195(11-12):690-3
pubmed: 22171867
J Stud Alcohol Drugs. 2017 Nov;78(6):844-852
pubmed: 29087818
Eur J Public Health. 2016 Feb;26(1):102-10
pubmed: 26142406
Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S76-S84
pubmed: 29573000
Drug Alcohol Rev. 2014 May;33(3):220-6
pubmed: 24329767
Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S115-S119
pubmed: 29431253
Drug Alcohol Depend. 2019 Jul 1;200:115-123
pubmed: 31121494
Subst Use Misuse. 2014 Oct;49(12):1692-715
pubmed: 25004138
Eur J Public Health. 2021 Apr 24;31(2):424-431
pubmed: 33188681
Addiction. 2020 Jul;115(7):1378-1381
pubmed: 32032446
Alcohol Clin Exp Res. 2015 Feb;39(2):350-4
pubmed: 25684054
Soc Sci Med. 2013 Nov;97:143-51
pubmed: 24161099
Drug Alcohol Depend. 2019 Jan 1;194:51-58
pubmed: 30399500
Scand J Public Health. 2016 Nov;44(7):654-662
pubmed: 27566999
Int J Drug Policy. 2020 Mar;77:102709
pubmed: 32120247
Child Dev. 2019 Mar;90(2):638-654
pubmed: 28925063
Alcohol Alcohol. 2012 Sep-Oct;47(5):581-90
pubmed: 22763231
Addiction. 2018 Jul;113(7):1317-1332
pubmed: 29484751
BMC Public Health. 2013 Aug 15;13:756
pubmed: 23947336
Drug Alcohol Rev. 2020 Sep;39(6):729-736
pubmed: 32367622
Drug Alcohol Rev. 2012 Jan;31(1):20-6
pubmed: 21355935
J Public Health (Oxf). 2015 Mar;37(1):40-9
pubmed: 25312002
Addiction. 2020 Nov;115(11):1987-1988
pubmed: 32080926
Drug Alcohol Depend. 2020 Feb 1;207:107821
pubmed: 31927161
J Stud Alcohol Drugs. 2016 Sep;77(5):730-9
pubmed: 27588531
Int J Drug Policy. 2020 Oct;84:102826
pubmed: 32721865
Lancet. 2007 Apr 21;369(9570):1391-1401
pubmed: 17448826
Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S34-S41
pubmed: 29473244

Auteurs

Gabriel Caluzzi (G)

Centre for Alcohol Policy Research, La Trobe University, Bundoora, Victoria, Australia.

Michael Livingston (M)

Centre for Alcohol Policy Research, La Trobe University, Bundoora, Victoria, Australia.
National Drug Research Institute, Curtin University, Perth, Western Australia, Australia.

John Holmes (J)

School of Health and Related Research, University of Sheffield, Sheffield, UK.

Sarah MacLean (S)

Centre for Alcohol Policy Research, La Trobe University, Bundoora, Victoria, Australia.
School of Allied Health, Human Services and Sport, La Trobe University, Bundoora, Victoria, Australia.

Dan Lubman (D)

Turning Point, Eastern Health, Melbourne, Victoria, Australia.
Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Australia.

Paul Dietze (P)

National Drug Research Institute, Curtin University, Perth, Western Australia, Australia.
Behaviours and Health Risks Program, Burnet Institute, Melbourne, Victoria, Australia.

Rakhi Vashishtha (R)

Centre for Alcohol Policy Research, La Trobe University, Bundoora, Victoria, Australia.

Rachel Herring (R)

Drug and Alcohol Research Centre, Middlesex University, London, UK.

Amy Pennay (A)

Centre for Alcohol Policy Research, La Trobe University, Bundoora, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH